ABTIDE Wellness Launches Direct-to-Consumer Platform: Clinical-Grade Nutrition, Direct
ABTIDE Wellness announces the launch of its direct-to-consumer platform, bringing pharmaceutical-grade ergothioneine, Gold-Ratio amino acid formulas, and clinical-grade probiotics directly to health-conscious consumers across North America.
A New Standard for Supplement Transparency
Vancouver, BC — ABTIDE Wellness today announced the full launch of its direct-to-consumer platform at abtidewellness.com, marking the first time the company's pharmaceutical-grade supplement lines have been available for direct purchase by individual consumers.
ABTIDE was founded on a premise that remains uncommon in the supplement industry: that the gap between the standards applied to pharmaceutical manufacturing and those applied to dietary supplement manufacturing is not acceptable when the underlying science is serious.
"The research on L-ergothioneine, Gold-Ratio amino acid formulations, and the gut-brain axis is rigorous and compelling," said the ABTIDE research team at launch. "The products that deliver these compounds to consumers should be held to the same quality standards as the research that established their efficacy. That is what we built."
Three Product Lines, One Quality Standard
The platform launches with three primary product lines, each built on a distinct body of clinical research:
The Amino Series — four formulas based on the Gold-Ratio essential amino acid architecture developed from NASA-funded research into astronaut muscle maintenance. The series addresses muscle protein synthesis efficiency across life stages, from athletic performance to age-related sarcopenia prevention.
The Ergothioneine Series — ABTIDE's proprietary DR.Ergo formulations, featuring the company's patented 99.99%-purity ergothioneine — the highest standard available commercially — alongside synergistic co-factors for cellular protection and mitochondrial function.
The Probiotic Series — two clinically designed probiotic formulas (6-Trillion and 4-Trillion CFU) built on 42 research-selected bacterial strains, encapsulated in six protective layers for guaranteed viable delivery to the colon.
An Essential Series rounds out the platform with targeted formulas addressing specific nutritional gaps in modern Western diets, including marine-source Omega-3s, bioavailable Calcium-Magnesium, high-potency Vitamin C, and Collagen Tripeptide.
The Direct Model: Why It Matters
The conventional supplement distribution model — manufacturer to distributor to retailer — involves multiple margin layers, each of which creates pressure to reduce ingredient quality, reduce dose concentrations, or both.
ABTIDE's direct-to-consumer model eliminates these intermediaries. The result is a company that can maintain the ingredient quality standards its research mandate requires while offering products at prices that reflect their actual production cost, not the cumulative margin stack of a multi-tier distribution system.
Customers ordering through abtidewellness.com receive products shipped directly from ABTIDE's climate-controlled fulfillment facility — the same temperature and humidity controls maintained throughout the manufacturing process to preserve the integrity of live probiotic cultures and the molecular stability of ergothioneine.
Scientific Transparency as Brand Architecture
ABTIDE's platform launch includes the full publication of its scientific library — research papers, clinical literature citations, and detailed formulation rationale for every product — in the INSIGHT section of abtidewellness.com.
This is deliberate. The supplement industry has a long history of invoking the language of science without the substance. The typical pattern is a clinical-sounding product name, a reference to a study on a related-but-not-identical compound, and vague claims about cellular health.
ABTIDE's approach is the opposite: specific claims, supported by specific citations, from specific research groups, on the specific compounds and formulations in each product.
The science is available. The reasoning is visible. The quality documentation is on request.
If a customer — or a healthcare provider, or a journalist — wants to evaluate whether ABTIDE's products are what they claim to be, everything required to do that is published.
What's Next
The launch platform represents ABTIDE's initial North American consumer offering. The company is in active discussion with healthcare provider networks for clinical distribution partnerships and with sports medicine facilities for professional athlete programs.
International expansion to markets in Asia-Pacific — where ergothioneine research is particularly advanced and consumer awareness of the molecule is highest — is planned for late 2026.
The DR.Ergo clinical program, which tracks ergothioneine biomarker levels in supplement users over a 12-month period, is currently enrolling participants. Results will be published on this platform as they emerge.
We built this company because the science deserved it. We launched this platform because the consumers who care about the science deserve direct access to the products built on it.
Welcome to ABTIDE.
ABTIDE Wellness — Precision Nutrition Backed by Science. Developed in Vancouver, Canada.